Skip to content

Clinical trials

Phase 2 Pemphigus trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pemphigus Phase: Phase 2 Country / region: United States Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20061
20072
20131
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated4

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)2
Jacobus Pharmaceutical1
Johns Hopkins University1
Kemia, Inc1
Massachusetts General Hospital1
NYU Langone Health1
Novartis Pharmaceuticals1
University of California, San Francisco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pemphigus9
Autoimmune Diseases2
Arthritis, Juvenile1
Arthritis, Rheumatoid1
Bronchiolitis Obliterans Syndrome1
COVID-191
Communicable Diseases1
Dermatomyositis1
Immune System Diseases1
Lichen Planus, Oral1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.